These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26972332)

  • 1. Comparison of the effects of long-term pimobendan and benazepril administration in normal cats.
    Miyagawa Y; Machida N; Toda N; Tominaga Y; Takemura N
    J Vet Med Sci; 2016 Aug; 78(7):1099-106. PubMed ID: 26972332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded, and randomized study.
    Chetboul V; Lefebvre HP; Sampedrano CC; Gouni V; Saponaro V; Serres F; Concordet D; Nicolle AP; Pouchelon JL
    J Vet Intern Med; 2007; 21(4):742-53. PubMed ID: 17708394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
    Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Åblad B; Bussadori CM; Glaus T; Kovačević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir A; Lynne O'Sullivan M; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
    J Vet Intern Med; 2013; 27(6):1441-51. PubMed ID: 24010489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J; Lord PF; Höglund K; Ljungvall I; Jöns O; Kvart C; Hansson K
    J Vet Intern Med; 2013; 27(6):1452-62. PubMed ID: 24128373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
    Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Ablad B; Bussadori CM; Glaus T; Kovacević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir AV; O'Sullivan ML; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
    J Vet Intern Med; 2008; 22(5):1124-35. PubMed ID: 18638016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a fixed-dose combination of benazepril and pimobendan in dogs with congestive heart failure: a randomized non-inferiority clinical trial.
    King JN; Hirakawa A; Sonobe J; Otaki H; Sakakibara N; Seewald W; Forster S
    J Vet Sci; 2018 Jan; 19(1):117-128. PubMed ID: 28693297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pimobendan on echocardiographic values in dogs with asymptomatic mitral valve disease.
    Ouellet M; Bélanger MC; Difruscia R; Beauchamp G
    J Vet Intern Med; 2009; 23(2):258-63. PubMed ID: 19143935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concerns about "Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded and randomized study".
    Le Bobinnec G
    J Vet Intern Med; 2008; 22(2):243-4; author reply 245-6. PubMed ID: 18371019
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of benazepril and pimobendan on serum angiotensin-converting enzyme activity in dogs.
    King JN; Christinaz C; Strehlau G; Hornfeld J
    J Vet Pharmacol Ther; 2018 Jun; 41(3):485-489. PubMed ID: 29392741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose pharmacokinetics and cardiovascular effects of oral pimobendan in healthy cats.
    Yata M; McLachlan AJ; Foster DJ; Hanzlicek AS; Beijerink NJ
    J Vet Cardiol; 2016 Dec; 18(4):310-325. PubMed ID: 27613648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerns about "Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease".
    Corcoran B; Culshaw G; Dukes-McEwan J; French A; Smith S; Swift S
    J Vet Intern Med; 2008; 22(2):243; author reply 245. PubMed ID: 18371020
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy.
    Vollmar AC; Fox PR
    J Vet Intern Med; 2016; 30(2):553-9. PubMed ID: 26936799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of benazepril, robenacoxib and their combination on glomerular filtration rate in cats.
    King JN; Panteri A; Graille M; Seewald W; Friton G; Desevaux C
    BMC Vet Res; 2016 Jun; 12(1):124. PubMed ID: 27338786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of a benazepril and pimobendan combination tablet in adult healthy dogs.
    Kuntz EA; Strehlau G; Giraudel JM; King JN
    J Vet Pharmacol Ther; 2018 Feb; 41(1):105-116. PubMed ID: 28649790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs.
    Lombard CW; Jöns O; Bussadori CM
    J Am Anim Hosp Assoc; 2006; 42(4):249-61. PubMed ID: 16822763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo-controlled clinical trial.
    King JN; Martin M; Chetboul V; Ferasin L; French AT; Strehlau G; Seewald W; Smith SGW; Swift ST; Roberts SL; Harvey AM; Little CJL; Caney SMA; Simpson KE; Sparkes AH; Mardell EJ; Bomassi E; Muller C; Sauvage JP; Diquélou A; Schneider MA; Brown LJ; Clarke DD; Rousselot JF
    J Vet Intern Med; 2019 Nov; 33(6):2559-2571. PubMed ID: 31560137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
    Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
    Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease.
    Sent U; Gössl R; Elliott J; Syme HM; Zimmering T
    J Vet Intern Med; 2015; 29(6):1479-87. PubMed ID: 26474314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of pimobendan in 170 cats (2006-2010).
    Macgregor JM; Rush JE; Laste NJ; Malakoff RL; Cunningham SM; Aronow N; Hall DJ; Williams J; Price LL
    J Vet Cardiol; 2011 Dec; 13(4):251-60. PubMed ID: 22030289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.